Azitra Postpones Special Meeting to Engage Shareholders Effectively Azitra, Inc. has announced the adjournment of its Special Meeting and scheduled a reconvened meeting to ensure shareholder engagement and voting participation.

Azitra Postpones Special Meeting to Engage Shareholders Effectively #United_States #Clinical_Trials #biotechnology #Branford #Azitra_Inc

Azitra, Inc. Refutes False Securities Offering Report Amid Concerns Azitra, Inc. quickly addresses a false report claiming a $44 million securities offering, urging stakeholders to rely on official communications.

Azitra, Inc. Refutes False Securities Offering Report Amid Concerns #United_States #ATR-12 #Branford #Netherton_syndrome #Azitra_Inc

Azitra, Inc. Engages in Strategic Reverse Stock Split to Enhance Market Position Azitra, Inc. has announced a reverse stock split intended to optimize its market position. This strategic move involves converting 6.66 shares into one effective August 21, 2025.

Azitra, Inc. Engages in Strategic Reverse Stock Split to Enhance Market Position #United_States #Stock_Split #ATR-12 #Branford #Azitra_Inc